Anygen Co., Ltd.

A196300

KR7196300008

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
14,860 ^KRW	+4.43%		+3.27%	+1.09%

Apr. 05	Anygen Co., Ltd. announced that it has received KRW 999.98709 million in funding	CI
Mar. 28	Anygen Co., Ltd. announced that it expects to receive KRW 999.98709 million in funding	CI

ANYGEN Co. Ltd. has completed an IPO in the amount of KRW 12.6 billion.

December 06, 2016 at 12:00 am EST

ANYGEN Co. Ltd. has completed an IPO in the amount of KRW 12.6 billion. Security Name: Shares Security Type: Common Stock Securities Offered: 700,000 PriceRange: KRW 18000 Transaction Features: Sponsor Backed Offering

Latest news about Anygen Co., Ltd.

Anygen Co., Ltd. announced that it has received KRW 999.98709 million in funding	Apr. 04	CI
Anygen Co., Ltd. announced that it expects to receive KRW 999.98709 million in funding	Mar. 27	CI
ANYGEN Co.,Ltd announced that it has received KRW 15 billion in funding from Atinum Investment Co., Ltd., Kiwoom Securities Co., Ltd., Investment Arm	18-06-07	CI
ANYGEN Co.,Ltd announced that it expects to receive KRW 15 billion in funding from Atinum Investment Co., Ltd., Kiwoom Securities Co., Ltd., Investment Arm	18-06-04	CI
An unknown buyer acquired 5.6% stake in ANYGEN Co.,Ltd from KDB Capital Corp.	17-02-07	CI
KDB Capital Corp. acquired 8.89% stake in ANYGEN Co. Ltd..	16-12-11	CI
ANYGEN Co. Ltd. has completed an IPO in the amount of KRW 12.6 billion.	16-12-06	CI
ANYGEN Co. Ltd. has filed an IPO.	15-08-12	CI

Chart Anygen Co., Ltd.

Duration

Period

More charts

Company Profile

ANYGEN CO., LTD. is a Korea-based company mainly engaged in manufacture and distribution of peptides. The Company's products mainly consist of leuprorelin acetate, desmopressin acetate, and contract manufacturing organization (CMO) peptides, which are used for pharmaceuticals; custom peptides, which is used for research, and argireline, which is used for cosmetics. The Company distributes its products within domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ANYGEN CO., LTD.	+1.09%	62.09M
NOVO NORDISK A/S	+24.17%	562B
JOHNSON & JOHNSON	-6.33%	358B
MERCK & CO., INC.	+19.90%	322B
ABBVIE INC.	+7.95%	297B
ASTRAZENECA PLC	+13.45%	219B
NOVARTIS AG	+6.04%	199B
ROCHE HOLDING AG	-10.51%	196B
PFIZER, INC.	-12.26%	149B
AMGEN INC.	-6.47%	146B